Clinical, Imaging Findings, Responses, and Outcomes of Patients With Classical Hodgkin Lymphoma and Non-Hodgkin Lymphoma Undergoing Immune Checkpoint Inhibitor Therapy: A Single-Institution Experience-Reference-Cited by-同舟云学术

Clinical, Imaging Findings, Responses, and Outcomes of Patients With Classical Hodgkin Lymphoma and Non-Hodgkin Lymphoma Undergoing Immune Checkpoint Inhibitor Therapy: A Single-Institution Experience

Published:2020-06-18 Issue:4 Volume:44 Page:619-626
ISSN:1532-3145
Container-title:Journal of Computer Assisted Tomography
language:en
Short-container-title:J Comput Assist Tomogr

Author:

Liput Joseph,Guler Ezgi,Smith Daniel A.,Tirumani Sree Harsha,Hoimes Christopher,Caimi Paolo F.,Ramaiya Nikhil H.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging

Reference25 articles.

1. Scientific rationale for immunotherapy in lymphoma and predictors of response;Ann Lymphoma,2017

2. PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma;N Engl J Med,2015

3. Nivolumab induces impressive responses in relapsed/refractory classic Hodgkin lymphoma: single institutional experience;J Oncol Pharm Pract,2019

4. Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma;Blood,2010

5. PD-L1 and PD-L2 genetic alterations define classical Hodgkin lymphoma and predict outcome;J Clin Oncol,2016

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune Checkpoint Inhibitors in Hodgkin Lymphoma and Non-Hodgkin Lymphoma;Immune Checkpoint Inhibitors - New Insights and Recent Progress;2023-03-08

2. [18F]FDG PET/CT Imaging in Cancer Treatment with Checkpoint Inhibitors;Handbook of Cancer and Immunology;2023

3. Interpretation of 2-[18F]FDG PET/CT in Hodgkin lymphoma patients treated with immune checkpoint inhibitors;European Radiology;2022-03-28

4. Incidence of Immune-Mediated Pseudoprogression of Lymphoma Treated with Immune Checkpoint Inhibitors: Systematic Review and Meta-Analysis;Journal of Clinical Medicine;2021-05-23